Ajay Matta - Search Results

Year	Number of Results
2005	1
2006	2
2007	1
2008	2
2009	6
2010	6
2011	7
2012	3
2013	4
2014	2
2015	4
2016	2
2017	2
2018	2
2020	1
2021	2
2022	1
2024	0

1

Injectable Biologics for the Treatment of Degenerative Disc Disease.

Matta A, Erwin WM. Matta A, et al. Curr Rev Musculoskelet Med. 2020 Dec;13(6):680-687. doi: 10.1007/s12178-020-09668-2. Curr Rev Musculoskelet Med. 2020. PMID: 32705541 Free PMC article. Review.

2

Current Status of the Instructional Cues Provided by Notochordal Cells in Novel Disc Repair Strategies.

Matta A, Erwin WM. Matta A, et al. Int J Mol Sci. 2021 Dec 31;23(1):427. doi: 10.3390/ijms23010427. Int J Mol Sci. 2021. PMID: 35008853 Free PMC article. Review.

3

14-3-3 zeta as novel molecular target for cancer therapy.

Matta A, Siu KW, Ralhan R. Matta A, et al. Expert Opin Ther Targets. 2012 May;16(5):515-23. doi: 10.1517/14728222.2012.668185. Epub 2012 Apr 18. Expert Opin Ther Targets. 2012. PMID: 22512284 Review.

4

Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.

Matta A, Ralhan R, DeSouza LV, Siu KW. Matta A, et al. Mass Spectrom Rev. 2010 Nov-Dec;29(6):945-61. doi: 10.1002/mas.20296. Mass Spectrom Rev. 2010. PMID: 20945361 Review.

5

Cell Clusters Are Indicative of Stem Cell Activity in the Degenerate Intervertebral Disc: Can Their Properties Be Manipulated to Improve Intrinsic Repair of the Disc?

Brown S, Matta A, Erwin M, Roberts S, Gruber HE, Hanley EN Jr, Little CB, Melrose J. Brown S, et al. Among authors: matta a. Stem Cells Dev. 2018 Feb 1;27(3):147-165. doi: 10.1089/scd.2017.0213. Epub 2018 Jan 16. Stem Cells Dev. 2018. PMID: 29241405 Review.

6

Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma.

Matta A, Ralhan R. Matta A, et al. Head Neck Oncol. 2009 Mar 2;1:6. doi: 10.1186/1758-3284-1-6. Head Neck Oncol. 2009. PMID: 19284526 Free PMC article. Review.

7

A comparative study of mesenchymal stem cell transplantation and NTG-101 molecular therapy to treat degenerative disc disease.

Matta A, Karim MZ, Gerami H, Benigno B, Erwin WM. Matta A, et al. Sci Rep. 2021 Jul 20;11(1):14804. doi: 10.1038/s41598-021-94173-w. Sci Rep. 2021. PMID: 34285277 Free PMC article.

8

Prognostic significance of nuclear pSTAT3 in oral cancer.

Macha MA, Matta A, Kaur J, Chauhan SS, Thakar A, Shukla NK, Gupta SD, Ralhan R. Macha MA, et al. Among authors: matta a. Head Neck. 2011 Apr;33(4):482-9. doi: 10.1002/hed.21468. Head Neck. 2011. PMID: 20652980

9

A Single Injection of NTG-101 Reduces the Expression of Pain-Related Neurotrophins in a Canine Model of Degenerative Disc Disease.

Matta A, Karim MZ, Gerami H, Benigno BZ, Cheng I, Mehrkens A, Erwin WM. Matta A, et al. Int J Mol Sci. 2022 May 20;23(10):5717. doi: 10.3390/ijms23105717. Int J Mol Sci. 2022. PMID: 35628530 Free PMC article.

10

NTG-101: A Novel Molecular Therapy that Halts the Progression of Degenerative Disc Disease.

Matta A, Karim MZ, Gerami H, Jun P, Funabashi M, Kawchuk G, Goldstein A, Foltz W, Sussman M, Eek BC, Erwin WM. Matta A, et al. Sci Rep. 2018 Nov 14;8(1):16809. doi: 10.1038/s41598-018-35011-4. Sci Rep. 2018. PMID: 30429487 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

43 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year